Venture&Growth
Location
Wayne (PA), USA
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
US-based MedTech company developing a novel venous stent.
Vesper Medical is a medical device company dedicated to the development of a novel venous stent for the treatment of a variety of venous diseases. The company had achieved CE Mark and has initiated the VIVID trial in the US for FDA approval. Vesper was founded in 2016 as a spin-out of Intact Vascular.
In 2022, Royal Philips acquired 100% of the Vesper shares, providing Gilde with an attractive return within a three-year holding period.
More Vesper Medical news
Philips acquires Gilde portfolio company Vesper Medical to further expand its image-guided therapy devices portfolio
Vesper Medical Announces First Enrollment in the VIVID Trial
Gilde Healthcare co-leads $37M financing of Vesper Medical to complete development of its Duo Venous Stent System
Venture&Growth
Acacia Pharma
Belgian Therapeutics company commercializing supportive care products to treat side effects of medical procedures.
Venture&Growth
Mobia Medical
Mobia Medical is a U.S.-based, growth-stage company commercializing the Vivistim Paired VNS System, an implantable neurostimulation therapy that improves outcomes for chronic ischemic stroke survivors with upper limb motor deficits. Vivistim Paired VNS System is an implantable neurostimulation therapy that
Venture&Growth
Wellinks / Spire Health
US-based Healthtech company providing remote patient monitoring solutions for COPD patients.
